Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2013
09/12/2013US20130237510 Method of treating neuroendocrine tumors
09/12/2013US20130237508 METHOD FOR PRODUCING y-ORYZANOL-CONTAINING FAT OR OIL
09/12/2013US20130237506 Stanol composition and the use thereof
09/12/2013US20130237505 Topical compositions for treatment of skin conditions
09/12/2013US20130237504 Pharmaceutical Forms and Methods for Designing the Same
09/12/2013US20130237503 Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin
09/12/2013US20130237499 Inhibitors of Human Immunodeficiency Virus Replication
09/12/2013US20130237498 Methods of use of biomaterial and injectable implant containing biomaterial
09/12/2013US20130237496 Active ingredient obtained from cichorium intybus for acting on the barrier function of the skin that is similar to that of vitamin d
09/12/2013US20130237494 Bone-targeting bisphosphonate duplex drugs
09/12/2013US20130237493 Combination therapy of 4-(cyclopropylamino)-2-(4-(4-(ethylsulfonyl)piperazin-1-yl)phenylamino)pyrimidine-5-carboxamide and fludarabine
09/12/2013US20130237492 Use of 2',5'-oligoadenylate derivative compounds
09/12/2013US20130237491 4'-substituted nucleoside derivatives as inhibitors of hcv rna replication
09/12/2013US20130237490 Novel antibacterial compounds, methods of making them, and uses thereof
09/12/2013US20130237488 Methods and compositions for treating inflammatory bowel disease
09/12/2013US20130237485 Methods and Agents for Enhancing Wound Healing
09/12/2013US20130237478 Compositions and methods for treatment of peripheral vascular disease
09/12/2013US20130237451 Compositions and methods for treatment of protein misfolding diseases
09/12/2013US20130236595 Food product providing sustained blood levels of exogenous substances
09/12/2013US20130236579 Cleanser compositions and methods for using the same
09/12/2013US20130236575 Compositions for the treatment of peripheral ulcers of various origins
09/12/2013US20130236573 Esketamine for the treatment of treatment-refractory or treatment-resistant depression
09/12/2013US20130236568 Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof
09/12/2013US20130236567 Gene expression signature as a predictor of chemotherapeutic response in breast cancer
09/12/2013US20130236557 Oil-in-Oil emulsified polymeric implants containing a hypotensive lipid and related methods
09/12/2013US20130236556 Compositions and methods relating to reduced mucoadhesion
09/12/2013US20130236555 Organic polymeric photon up-conversion nanoparticles for biological applications
09/12/2013US20130236554 Dosage forms for oral administration and methods of treatment using the same
09/12/2013US20130236553 Compositions and Methods for the Delivery of Therapeutics
09/12/2013US20130236552 Nanotopography-mediated reverse uptake platform for nucleic acid delivery and applications thereof
09/12/2013US20130236551 Combination composition useful for treating cardiovascular diseases
09/12/2013US20130236550 Pharmaceutical microparticles
09/12/2013US20130236549 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
09/12/2013US20130236545 Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria
09/12/2013US20130236543 Pharmaceutical composition and uses thereof
09/12/2013US20130236542 Slow release magnesium composition and uses thereof
09/12/2013US20130236541 Pharmaceutical combination comprising an ibat inhibitor and a bile acid binder
09/12/2013US20130236540 Oral dosage form of 25-hydroxyvitamin d
09/12/2013US20130236539 Method of reducing somnolence in patients treated with tizanidine
09/12/2013US20130236538 Pharmaceutical compositions of ibuprofen and famotidine
09/12/2013US20130236537 Pharmaceutical preparation for tumor chemotherapy and method for producing the same
09/12/2013US20130236536 Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein
09/12/2013US20130236531 Pharmaceutical composition including an hif-2 alpha inhibitor as an active ingredient for preventing or treating arthritis
09/12/2013US20130236527 Licorice lollipop that inhibits dental caries formation
09/12/2013US20130236526 Sustained Release Intraocular Implants and Methods for Preventing Retinal Dysfunction
09/12/2013US20130236525 Sustained release intraocular implants and related methods
09/12/2013US20130236524 Silicone coated implant
09/12/2013US20130236516 Felbinac-Containing External Patch
09/12/2013US20130236515 Levalbuterol salt
09/12/2013US20130236514 Pharmaceutical Compositions Comprising Terbinafine
09/12/2013US20130236510 Multiplexed supramolecular assemblies for non-viral delivery of genetic material
09/12/2013US20130236504 Delivery System for Enhancing Drug Efficacy
09/12/2013US20130236501 Injectable Emulsion of Sedative Hypnotic Agent
09/12/2013US20130236500 Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same
09/12/2013US20130236499 Segmented, Semicrystalline Poly(Lactide-co-epsilon-Caprolactone) Absorbable Copolymers
09/12/2013US20130236498 Biodegradable supporting device
09/12/2013US20130236496 Use of leukotriene b4 in combination with a toll-like receptor ligand, a rig-i-like receptor ligand, or a nod-like receptor ligand to enhance the innate immune response
09/12/2013US20130236480 Transglutaminase 2 inhibitors for use in the prevention or treatment of rapidly progressive glomerulonephritis
09/12/2013US20130236477 Methods for Promoting Reinnervation of Auditory Hair Cells
09/12/2013US20130236473 Therapeutic agents and prophylactic agents for symptoms accompanying autoimmune diseases, inflammatory diseases, allergy diseases and organ transplants
09/12/2013US20130236472 Compounds and mixtures for influencing inflammatory states
09/12/2013US20130236469 Vaccine against streptococcal infections based on recombinant proteins
09/12/2013US20130236468 Benzodioxane inhibitors of leukotriene production for combination therapy
09/12/2013US20130236453 Methods and Compositions for Modulating Acute Graft-versus-Host Disease using miR-155 Specific Inhibitors
09/12/2013US20130236449 Methods of enhancing antibody-dependent cellular cytotoxicity
09/12/2013US20130236438 Composition for Treating Phonatory and Olfactory Apparatus Disorders
09/12/2013US20130236437 Compositions, kits and methods for treatment of cardiovascular, immunological and inflammatory diseases
09/12/2013US20130236433 Methods, compositions, cells, and kits for treating ischemic injury
09/12/2013US20130236424 Oligosaccharide composition for treating acute respiratory tract infections
09/12/2013US20130236423 Oligosaccharide mixture and food product comprising this mixture, especially infant formula
09/12/2013US20130236420 Silibinin component for the treatment of hepatitis
09/12/2013US20130236404 Substances and compositions for enhancing dna repair and methods of use
09/12/2013US20130236394 Thioflavin derivatives for use in antemortem diagnosis of alzheimer`s disease and in vivo imaging and prevention of amyloid deposition
09/12/2013US20130233748 Abuse Potential Reduction in Abusable Substance Dosage Form
09/11/2013EP2636742A1 Induction of exon skipping in eukaryotic cells
09/11/2013EP2636741A1 Induction of exon skipping in eukaryotic cells
09/11/2013EP2636740A1 Induction of exon skipping in eukaryotic cells
09/11/2013EP2636739A1 iRNA agents targeting VEGF
09/11/2013EP2636736A1 Novel anti-dr5 antibody
09/11/2013EP2636735A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses
09/11/2013EP2636677A1 Cdk-inhibiting pyrrolopyrimidinone carboxamide derivative or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient for preventing or treating liver cell cancer
09/11/2013EP2636675A1 Diphosphonate compounds and preparation method and use thereof
09/11/2013EP2636673A1 Aminomethylene pyrazolones with therapeutic activity
09/11/2013EP2636672A1 Imidazole derivatives and preparation method and use thereof
09/11/2013EP2636671A1 Organic amine salt of aminobenzoic acid derivative, and method for producing same
09/11/2013EP2636667A1 Benzamide derivative with anticancer activity and preparation method and use thereof
09/11/2013EP2636666A1 Trans-2-decenoic acid derivative and medicament containing same
09/11/2013EP2636663A1 Novel dihydroxybenzene derivatives and antiprotozoal agent comprising same as active ingredient
09/11/2013EP2636414A1 Preventive or therapeutic agent for pain associated with herpes zoster in acute phase
09/11/2013EP2636411A1 Epimerization of 4'-c bond and modification of 14-ch3-(co)-fragment in anthracyclin antibiotics
09/11/2013EP2636410A1 Utilization of the dichlorido complexes of platinum with 7-azaindole halogeno-derivatives for the preparation of drugs for the treatment of tumour diseases
09/11/2013EP2636409A1 Combined pharmaceutical composition as antifungal agent
09/11/2013EP2636408A1 Patch
09/11/2013EP2636407A2 Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome
09/11/2013EP2636406A1 Ibuprofen Intravenous Infusion
09/11/2013EP2636405A1 Felbinac-containing external patch
09/11/2013EP2636404A2 Methods of Treating Non-Alcoholic Steatohepatitis (Nash) Using Cysteamine Products
09/11/2013EP2636307A1 Antimicrobial compostion containing free fatty acids and method for its production
09/11/2013EP2635709A2 Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
09/11/2013EP2635707A1 Method of examining polycystic kidney disease and method of screening for therapeutic agent of the disease
1 ... 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 ... 7860